Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

During the Trading Day
46.05 +0.17 / +0.37%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
45.98 -0.07 / -0.15%
 
Volume: 225.00

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month-24.07% 3 years+13.54%
3 months-35.58% 5 years+17.78%
1 year-28.66% Since inception+11.15%
Data through 02/10/2016

Quote Details

Previous close$45.88
Open day’s range45.88 – 48.14
Net asset value (NAV)45.90 (02/09/2016)
Daily volume7,622,291
Average volume (3 months)5,687,771
Data as of 3:59pm ET, 02/10/2016

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+17.78%+20.72%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio0.771.06
Net assets$1.5B$1.4B
Average market cap$2.6B$36.5B
Average P/E--22.4
Dividend / Share--0.22%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BXLT Baxalta Inc2.16%
ABBV AbbVie2.03%
AMGN Amgen1.97%
XON Intrexon Corp1.96%
CPHD Cepheid1.94%
LGND Ligand Pharmaceuticals Inc1.94%
BIIB Biogen1.93%
CELG Celgene1.86%
MYGN Myriad Genetics Inc1.85%
AMAG AMAG Pharmaceuticals Inc1.71%

Partner Offers